Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akshay Desai

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Clinical Cardiology|October 2, 2019
Patients report more severe daily limitations than recognized by their physiciansRenata R T Castro, Emer Joyce, Neal K Lakdawala, et al.
JACC. Heart Failure|July 11, 2016
Efficacy of Sacubitril/Valsartan Relative to a Prior Decompensation: The PARADIGM-HF TrialScott D Solomon, Brian Claggett, Milton Packer, et al.
Hypertension (Dallas, Tex. : 1979)|December 10, 2009
Effect of intensive versus standard blood pressure lowering on diastolic function in patients with uncontrolled hypertension and diastolic dysfunctionScott D Solomon, Anil Verma, Akshay Desai, et al.
JACC. Heart Failure|November 15, 2020
Cardiovascular and Renal Outcomes of Mineralocorticoid Receptor Antagonist Use in PARAGON-HFKarola S Jering, Faiez Zannad, Brian Claggett, et al.
European Heart Journal|May 9, 2026
Guideline-recommended medical therapy efficacy according to use of digoxin: RALES, EMPHASIS-HF, PARADIGM-HF, and DAPA-HF trialsRagnhild Helseth, Ryohei Ono, Brian Claggett, et al.
JACC. Heart Failure|February 15, 2016
Variable Contribution of Heart Failure to Quality of Life in Ambulatory Heart Failure With Reduced, Better, or Preserved Ejection FractionEmer Joyce, Christine Chung, Sabrina Badloe, et al.
European Heart Journal|September 17, 2015
Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fractionScott D Solomon, Brian Claggett, Eldrin F Lewis, et al.
Journal of Cardiac Failure|March 17, 2019
Nutrition, Obesity, and Cachexia in Patients With Heart Failure: A Consensus Statement from the Heart Failure Society of America Scientific Statements CommitteeAmanda R Vest, Michael Chan, Anita Deswal, et al.
European Heart Journal|February 15, 2011
Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunctionScott D Solomon, Sung Hee Shin, Amil Shah, et al.
Circulation. Heart Failure|October 12, 2017
Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial FibrillationSøren Lund Kristensen, Pardeep S Jhund, Ulrik M Mogensen, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Clinical Cardiology|October 2, 2019
Patients report more severe daily limitations than recognized by their physiciansRenata R T Castro, Emer Joyce, Neal K Lakdawala, et al.
JACC. Heart Failure|July 11, 2016
Efficacy of Sacubitril/Valsartan Relative to a Prior Decompensation: The PARADIGM-HF TrialScott D Solomon, Brian Claggett, Milton Packer, et al.
Hypertension (Dallas, Tex. : 1979)|December 10, 2009
Effect of intensive versus standard blood pressure lowering on diastolic function in patients with uncontrolled hypertension and diastolic dysfunctionScott D Solomon, Anil Verma, Akshay Desai, et al.
JACC. Heart Failure|November 15, 2020
Cardiovascular and Renal Outcomes of Mineralocorticoid Receptor Antagonist Use in PARAGON-HFKarola S Jering, Faiez Zannad, Brian Claggett, et al.
European Heart Journal|May 9, 2026
Guideline-recommended medical therapy efficacy according to use of digoxin: RALES, EMPHASIS-HF, PARADIGM-HF, and DAPA-HF trialsRagnhild Helseth, Ryohei Ono, Brian Claggett, et al.
JACC. Heart Failure|February 15, 2016
Variable Contribution of Heart Failure to Quality of Life in Ambulatory Heart Failure With Reduced, Better, or Preserved Ejection FractionEmer Joyce, Christine Chung, Sabrina Badloe, et al.
European Heart Journal|September 17, 2015
Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fractionScott D Solomon, Brian Claggett, Eldrin F Lewis, et al.
Journal of Cardiac Failure|March 17, 2019
Nutrition, Obesity, and Cachexia in Patients With Heart Failure: A Consensus Statement from the Heart Failure Society of America Scientific Statements CommitteeAmanda R Vest, Michael Chan, Anita Deswal, et al.
European Heart Journal|February 15, 2011
Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunctionScott D Solomon, Sung Hee Shin, Amil Shah, et al.
Circulation. Heart Failure|October 12, 2017
Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial FibrillationSøren Lund Kristensen, Pardeep S Jhund, Ulrik M Mogensen, et al.
Pageof 4